---
title: "Weigao Orthopaedic: The preliminary inquiry transfer price is set at RMB 21.10 per share"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/223404906.md"
description: "Weigao Orthopaedic has preliminarily set the inquiry transfer price at RMB 21.10 per share. A total of 13 institutional investors participated in the bidding, with valid subscriptions amounting to 8.67 million shares, resulting in a valid subscription multiple of 1.64 times. The shares for this transfer have been fully subscribed, with the transferees being 12 institutional investors, intending to acquire a total of 5.28 million shares"
datetime: "2024-12-27T08:12:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/223404906.md)
  - [en](https://longbridge.com/en/news/223404906.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/223404906.md)
generator: "portal-rs"
---

# Weigao Orthopaedic: The preliminary inquiry transfer price is set at RMB 21.10 per share

According to the Zhitong Finance APP, Weigao Orthopaedic (688161.SH) disclosed the pricing situation for the transfer of shares through shareholder inquiry. After inquiring with institutional investors, the preliminary transfer price has been set at RMB 21.10 per share. A total of 13 institutional investors participated in this inquiry transfer, including fund management companies, securities firms, and private equity fund managers. The total number of shares effectively subscribed by the participating institutional investors was 8.67 million shares, corresponding to an effective subscription multiple of 1.64 times. The shares intended for transfer in this inquiry have been fully subscribed, with the preliminary determined transferees being 12 institutional investors, intending to acquire a total of 5.28 million shares

### Related Stocks

- [688161.CN](https://longbridge.com/en/quote/688161.CN.md)
- [399975.CN](https://longbridge.com/en/quote/399975.CN.md)

## Related News & Research

- [Goldman Upgrades Humanoid Forecast By 4 Times As Warehouses Become Ground Zero For Deployments](https://longbridge.com/en/news/297570687.md)
- [Kuwait Investment Authority cuts GEA stake to 6.99% from 10.5%](https://longbridge.com/en/news/298000996.md)
- [Fortum wins regulatory clearance for NOK 47-a-share Elmera bid](https://longbridge.com/en/news/297866660.md)
- [DOF Group CFO Lundberg sells 25,000 shares at NOK 132 each](https://longbridge.com/en/news/297912831.md)
- [Mabwell reports Phase Ib/IIa data showing anti-ST2 antibody 9MW1911 cuts COPD exacerbations up to 81%](https://longbridge.com/en/news/298042457.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**